Track topics on Twitter Track topics that are important to you
The Æterna Zentaris group is comprised of healthcare-oriented companies evolving predominantly in the biopharmaceutical as well as personal care industries. Its success depends upon scientific and clinical expertise, financial acumen and sound market knowledge. The Æterna Zentaris group’s reliance at all levels on top-flight minds and specialty-focused partner organizations is foundational to its success. This emphasis on retaining the finest strategic talent informs every aspect of its corporate culture.
Æterna Zentaris owns 100% of the biopharmaceutical company, Zentaris GmbH, based in Frankfurt, Germany and 100% of Echelon Biosciences Inc., a privately-held biopharmaceutical company based in Salt Lake City, Utah/USA. Æterna Zentaris also owns 48.29% of the equity of Atrium Biotechnologies Inc. (TSX: ATB) and 64.7% of its voting rights. Atrium is a developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutritional industries.
The Æterna Zentaris group has over 350 employees in North America and Europe.
1405 boul. du Parc-Technologique
Phone: (418) 652-8525
Fax: (418) 652-0881
The share price of Canada-based Aeterna Zentaris’ had shot up by nearly 200% to $3.01 by Friday lunchtime…
Aeterna Zentaris (WKN: A1439Z) knallt heute unter hohem Umsatz zeitweise über 90% in die Höhe. Das Unternehmen meldete gestern nachbörslich einen PDUFA-Termin für sein Macrilen-Präparat. Die Akti...
Troubled US biotech Aeterna Zentaris has called in outside help to assist with a strategic review after a disastrous few months that saw the company axe its CEO, David Dodd. Things got even worse las...
Thursday, July 20th 2017 at 9:00pm UTC CHARLESTON, S.C.–(BUSINESS WIRE)– Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), announced today that it has formed a special ...
Friday, August 4th 2017 at 9:00pm UTC CHARLESTON, S.C.–(BUSINESS WIRE)– Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”) will announce its second quarter 2017 financial...
Aeterna Zentaris Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Aeterna Zentaris Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment...
Life Sciences Jobs ...
Life Sciences Jobs ...
The Æterna Zentaris group is comprised of healthcare-oriented companies evolving predominantly in the biopharmaceutical as well as personal care industries. Its success depends upon scientific and cl...
Committed to cure by discovering and developing innovative drugs for the treatment of patients suffering from some forms of cancer, endocrinian disorders and infectious diseases, this is our mission. ...
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and womenâs health. We are eng...
Æterna Laboratories Inc. is a biopharmaceutical company focused on the treatment of cancer. The company’s lead product, Neovastat®, is the focus of a number of clinical trials including pivotal tr...
We have published hundreds of Æterna Zentaris Inc news stories on BioPortfolio along with dozens of Æterna Zentaris Inc Clinical Trials and PubMed Articles about Æterna Zentaris Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Æterna Zentaris Inc Companies in our database. You can also find out about relevant Æterna Zentaris Inc Drugs and Medications on this site too.
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...